National Natural Science Foundation of China(No.82370164);Sanming Project of Medicine in Shenzhen(No.SZSM202011004);Shenzhen Science and Technology Innovation Commission(JCYJ20180307150419435 and JCYJ20210324123004011).
Background:Chimeric antigen receptor T(CAR-T)cell therapy has achieved marked therapeutic success in ameliorating hematological malignancies.However,there is an extant void in the clinical guidelines concerning the mo...
supported by grants from the Natural Science Foundation of Zhejiang Province(No.LY19H150007,G.SZ);National Natural Science Foundations of China(No.81971871,G.SZ;No.81901941,S.F.Z.);National Key R&D Program of China(2017YFC1310604,H.Q.H.).
Angiotensin-converting enzyme 2(ACE2)is the receptor for severe acute respiratory syndrome coronavirus(SARS-CoV)and SARS-CoV-2 and is upregulated after infection with these viruses,which assists the entry of these vir...
supported by the National Natural Science Foundation of China(No.81770187);the National Key Research and Development Plan of China(No.2017YFA0104500).
Post-transplantation cyclophosphamide(PT-Cy)alone or in combination with other immunosuppressive drugs has emerged as a promising strategy in the setting of allogeneic hematopoietic stem cell transplantation.Improved ...
Immunotactoid gloemrulonephritis is a glomerular disease characterized by organized microtubular deposits of monoclonal immunoglobulin. These deposits are Congo red-negative, have hollow centers, measure > 30 nm, and ...
Supported by a grant from the Planned Science and Technology Project of Guangzhou (No. 2006Z3-E0401)
Objective: To evaluate the therapeutic effect of the fludarabine and cytarabine (FA) regimen on acute myeloid leukemia (AML) at different phases during treatment. Methods: A total of 185 patients with AML were divided...
OBJECTIVE To evaluate the clinical effectivity and toxicity of the regimen FMD (fludarabine, mitoxantrone, dexamethasone) in patients with non-Hodgkin's lymphoma. METHODS Thirty-two patients, twenty-four of whom ha...
Background Relapse remains an obstacle to successful allogeneic haematopoietic stem cell transplantation (allo-HSCT) for patients with acute leukaemia and no standard treatment is available. We assessed fludarabine ...